Drug dealers in Bahrain have been misrepresenting dangerous synthetic narcotics as legitimate therapeutic medications, according to reports. This deceptive practice aims to obscure the harmful nature of these substances and facilitate their distribution. Synthetic hashish products are being marketed fraudulently as cannabidiol, commonly known as CBD, which is recognized for potential medical applications.
The distinction between illicit synthetic drugs and genuine therapeutic compounds is critical for public health. Cannabidiol is a non-intoxicating cannabis component studied for medicinal purposes, whereas synthetic hashish carries significant health risks. Consumers purchasing these counterfeit products face unknown dangers and lack proper medical oversight.
Authorities emphasize the importance of purchasing medications through legitimate channels and verified healthcare providers. The public is advised to exercise caution when encountering products claiming therapeutic benefits outside official distribution networks. Education and awareness campaigns remain essential in protecting community members from fraudulent drug schemes.
Source: GDN Online | May 08, 2026